
Уникальное путешествие Семаглутида
Журнал: Non nocere. Новый терапевтический журнал. 2026;(10):80-87.
Прочитано: 200 раз
Резюме
Кардиометаболическая революция свершилась.
Дата публикации: 09.11.2026
Литература / References
- Драпкина О.М., Самородская И.В., Старинская М.А., Ким О.Т., Неймарк А.Е. Ожирение: оценка и тактика ведения пациентов. – Москва: ФГБУ «НМИЦ ТПМ» Минздрава России; ООО «Силицея-Полиграф», 2021. – 174 с.
- Ndumele CE, Rodriguez F, Dixon DL, et al. 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2026;87(22S):e1889–e2007. https://doi.org/10.1016/j.jacc.2026.03.056
- Marso SP, Bain SC, Consoli A, et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med. 2016;375(19):1834-1844. https://doi.org/10.1056/NEJMoa1607141
- Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. https://doi.org/10.1056/NEJMoa2307563
- Ryan DH, Lingvay I, Colhoun HM, et al. Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design. Am Heart J. 2020;229:61-69. https://doi.org/10.1016/j.ahj.2020.07.008
- Kosiborod MN, Abildstrøm SZ, Borlaug BA, et al. Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity. N Engl J Med. 2023;389(12):1069-1084. https://doi.org/10.1056/NEJMoa2306963
- Verma S, Cosentino F, Kosiborod MN. Pump, pipes, filter, sugar, weight, and more: the pluripotent prowess of semaglutide. Eur Heart J. 2025;46(12):1109-1111. https://doi.org/10.1093/eurheartj/ehae744
- Hu Y, Zhao Y, Dai N, et al. GLP-1R agonists and heart failure: novel beneficial effects suggested by Mendelian randomization. Eur Heart J. 2026;47(19):2308-2322. https://doi.org/10.1093/eurheartj/ehaf1066
- Monzo L, Savarese G, Mullens W, et al. Pharmacological treatment for patients with obesity and heart failure: Focus on glucagon-like peptide-1 receptor agonists. European Journal of Heart Failure expert consensus document. Eur J Heart Fail. 2025;27(11):2465-2479. https://doi.org/10.1002/ejhf.70082
- Lim S, Meigs JB. Links between ectopic fat and vascular disease in humans. Arterioscler Thromb Vasc Biol. 2014;34(9):1820-1826. https://doi.org/10.1161/ATVBAHA.114.303035



